Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Apheresis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01753453
What this trial is testing

An Exploratory Safety Study to Investigate the Extent of Tumor Cell Mobilization (TCM) After Use of G-CSF Alone or G-CSF Plus Plerixafor in Multiple Myeloma (MM) Patients Who May be Poor Mobilizers of Stem Cells

Who this might be right for
Multiple Myeloma
Sanofi 23
Large-scale testing (Phase 3)Ended earlyNCT00074763
What this trial is testing

Comparing Fresh Random Platelets and Autologous Cryopreserved Thrombosol Treated Autologous Platelets

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 4
Not applicableStudy completedNCT04253756
What this trial is testing

Trial Examining Plasma Exchange Using the Becton Dickinson (BD) Catheter In an Outpatient Apheresis Unit

Who this might be right for
Plasma Exchange
University of Texas Southwestern Medical Center 26
Not applicableStudy completedNCT05012462
What this trial is testing

Clinical Evaluation of the CM-1500 During Apheresis Blood Donation

Who this might be right for
Fluid Loss
Zynex Monitoring Solutions 77
Not applicableEnded earlyNCT02120482
What this trial is testing

Combined Apheresis for ABO-incompatible Transplantation - a Pilot Study

Who this might be right for
Decreased Immunologic ActivityAntibody-mediated Rejection
Medical University of Vienna 4
Not applicableEnded earlyNCT00031174
What this trial is testing

Blood Component Collection From Patients With Rheumatic or Kidney Disease and Healthy Volunteers

Who this might be right for
Rheumatic DiseasesHealthy Volunteers
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 151
Not applicableStudy completedNCT00042627
What this trial is testing

Prevalence and Risk of Cataracts in Granulocyte Donors

Who this might be right for
Apheresis
National Eye Institute (NEI) 252
Not applicableStudy completedNCT04320823
What this trial is testing

IMPACT (Improving Plasma Collection) Clinical Trial

Who this might be right for
Apheresis Related Hypotension
Haemonetics Corporation 3,443
Testing effectiveness (Phase 2)Study completedNCT00001873
What this trial is testing

The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood Cancers

Who this might be right for
Chronic Lymphocytic LeukemiaGraft vs Host DiseaseHematologic Neoplasm+2 more
National Heart, Lung, and Blood Institute (NHLBI) 102
Not applicableEnded earlyNCT00562601
What this trial is testing

LCI Apheresis to Obtain Plasma or White Blood Cells

Who this might be right for
Apheresis
National Institute of Allergy and Infectious Diseases (NIAID) 864
Large-scale testing (Phase 3)Study completedNCT02326220
What this trial is testing

Study of Alirocumab (REGN727/SAR236553) in Patients With Heterozygous Familial Hypercholesterolemia (HeFH) Undergoing Low-density Lipoprotein (LDL) Apheresis Therapy

Who this might be right for
Heterozygous Familial Hypercholesterolemia
Regeneron Pharmaceuticals 62
Testing effectiveness (Phase 2)Ended earlyNCT01013168
What this trial is testing

Clinical Study of OncoSorb® in Patients With Advanced Cancer Entities

Who this might be right for
Advanced Cancer Entities
BioPheresis GmbH 4
Not applicableEnded earlyNCT00714272
What this trial is testing

Granulocytapheresis in Psoriasis

Who this might be right for
Psoriasis
EXcorLab GmbH 4
Large-scale testing (Phase 3)Active Not RecruitingNCT05900141
What this trial is testing

An Open Label Extension (OLE) Study to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

Who this might be right for
Hyperlipoproteinemia (a)
Novartis Pharmaceuticals 41
Large-scale testing (Phase 3)Study completedNCT00943306
What this trial is testing

Long Term, Follow-on Study of Lomitapide in Patients With Homozygous Familial Hypercholesterolemia

Who this might be right for
Familial Hypercholesterolemia
Aegerion Pharmaceuticals, Inc. 19
Not applicableStudy completedNCT01736657
What this trial is testing

Evaluation of Spectra Optia Red Blood Cell Exchange in Sickle Cell Patients

Who this might be right for
Sickle Cell Disease
Terumo BCT 73
Early research (Phase 1)Study completedNCT00005785
What this trial is testing

Stem Cell (Modified Bone Marrow) Transplantation in HIV-Infected Patients With Blood Cancer

Who this might be right for
Hematologic NeoplasmHIV Infection
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 30
Testing effectiveness (Phase 2)Study completedNCT00006184
What this trial is testing

Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple Myeloma

Who this might be right for
Multiple Myeloma
National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Ended earlyNCT02286284
What this trial is testing

Usefulness of Extracorporeal Removal of sFLT-1 in Women With Very Early Severe Preeclampsia

Who this might be right for
Preeclampsia
Assistance Publique - Hôpitaux de Paris 2
Testing effectiveness (Phase 2)Study completedNCT00651937
What this trial is testing

Trial of Two Stem Cell Doses To Reduce Transplant Induced Symptom Burden

Who this might be right for
Multiple MyelomaPrimary Amyloidosis
M.D. Anderson Cancer Center 80
Next Page